Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans

Journal of International Medical Research

Volumn 32, Issue 2, 2004, Pages 166-169

  Yamakawa, J ^a   Takahashi, T ^a   Saegusa, S ^a   Moriya, J ^a   Itoh, T ^a   Kusaka, K ^a   Kawaura, K ^a   Wang, X Q ^a   Kanda, T ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis obliterans; Atherosclerosis; Diabetes mellitus; Interleukin 18; Sarpogrelate; Serotonin

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPROTEIN; SARPOGRELATE; SEROTONIN ANTAGONIST; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLD SENSATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; HUMAN; LIPOPROTEIN BLOOD LEVEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 1642487734     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200209     Document Type: Article

References (14)

1. Piot C, Fontbonne A, Sultan A, Rasamisoa M, Mariano-Goulant D, Davy JM, et al: Inflammatory parameters are independent predictors of severe epicardial coronary stenosis in asymptomatic diabetic patients with silent myocardial ischemia. Diabetes Care 2003; 26: 545 - 546.
2. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000; 148: 209 - 214.
3. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88 - 91.
4. Netea MG, Kullberg BJ, Verschueren I, Van Der Meer JW: Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1 beta. Eur J Immunol 2000; 30: 3957 - 3060.
5. Kawasaki D, Tsujino T, Morimoto S, Fujioka Y, Naito Y, Okumura T, et al: Usefulness of circulating interleukin-18 concentration in acute myocardial infarction as a risk factor for late restenosis after emergency coronary angioplasty. Am J Cardiol 2003; 91: 1258 - 1261.
6. Katz MF, Farber HW, Dodds-Stitt Z, Cruikshank WW, Beer DJ: Serotonin-stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor. J Leukoc Biol 1994; 55: 567 - 573.
7. Maxwell C: Sensitivity and accuracy of the visual analogue scale: A psycho-physical classroom experiment. Br J Clin Pharmacol 1978; 6: 15 - 24.
8. Ito T, Ikeda U, Shimpo M, Yamamoto K, Shimada K: Serotonin increases interleukin-6 synthesis in human vascular smooth muscle cells. Circulation 2000: 102: 2522 - 2527.
9. Frishman WH, Huberfeld S, Okin S, Wang YH, Kumar A, Shareef B: Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J Clin Pharmacol 1995; 35: 541 - 572.
10. Schini-Kerth VB, Fisslthaler B, Van Obberghen-Schilling E, Busse R: Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells. Role of protein kinase C and protein tyrosine kinases. Circulation 1996; 93: 2170 - 2177.
11. Van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ: Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 1989; 79: 116 - 124.
12. Furukawa K, Tanabe T, Hoshino S, Mishima Y, Shionoya K, Yoshizaki S, et al: Therapeutic effects of sarpogrelate hydrochloride (MCI-9042) on chronic arterial occlusive diseases: A double-blind comparison with ticlopidine hydrochloride. Rinsho Iyaku 1991; 7: 1747 - 1770.
13. Takahashi T, Yano M, Minami J, Haraguchi T, Koga N, Higashi K, et al: Sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. Diabetes Res Clin Pract 2002; 58: 123 - 129.
14. Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, et al: Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 2003; 52: 605 - 608.